ABSTRACT
Background Cross sectional measures of body mass index (BMI) are associated with cardiovascular disease (CVD) incidence, but less is known about whether weight change affects the risk of CVD.
Methods We estimated the effect of 2-year weight change interventions on 7-year risk of CVD, by emulating hypothetical target trials using electronic health records. We identified 138.567 individuals in England between 1998 and 2016, aged 45-69 years old, free of chronic diseases at baseline. We performed pooled logistic regression, using inverse-probability weighting to adjust for baseline and time-varying variables. Each individual was classified into a weight loss, maintenance, or gain group.
Findings In the normal weight, both weight loss and gain were associated with increased risk for CVD [HR vs weight maintenance=1.53 (1.18-1.98) and 1.43 (1.19-1.71 respectively)]. Among overweight individuals, both weight loss and gain groups, compared to weight maintenance, had a moderately higher risk of CVD [HR=1.20 (0.99−1.44) and 1.17 (0.99−1.38), respectively]. In the obese, weight loss had a lower risk lower risk of CHD [HR =0.66 (0.49−0.89)] and a moderately lower risk of CVD [HR =0.90 (0.72−1.13)]. When we assumed that a chronic disease occurred 1-3 years before the recorded date, estimates for weight loss and gain were attenuated among overweight individuals and estimates for weight loss were stronger among individuals with obesity.
Interpretation Among individuals with obesity, the weight loss group had a lower risk of CHD and moderately lower risk of CVD. Weight gain increased the risk of CVD across BMI groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MK is funded by the British Heart Foundation (grant: FS/18/5/33319). KDO is supported by UK Wellcome Trust Institutional Strategic Support Fund- LSHTM Fellowship 204928/Z/16/Z. SD is supported by an Alan Turing Fellowship. R.T.L. is supported by a UK Research and Innovation Rutherford Fellowship. AGL is funded by the Wellcome Trust (204841/Z/16/Z), the NIHR Great Ormond Street Hospital Biomedical Research Centre (19RX02) and the NIHR University College London Hospitals Biomedical Research Centre (BRC714a/HI/RW/101440). HH is a National Institute for Health Research (NIHR) Senior Investigator.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
N/A
